Pages that link to "Q73409468"

The following pages link to Hengjiang Dong (Q73409468):

Displaying 47 items.

• Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice (Q24302828) (← links)
• FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice (Q28507512) (← links)
• Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice (Q28511006) (← links)
• Foxo1 mediates insulin-like growth factor 1 (IGF1)/insulin regulation of osteocalcin expression by antagonizing Runx2 in osteoblasts (Q28591040) (← links)
• Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction (Q29619822) (← links)
• Proteomic analysis of fructose-induced fatty liver in hamsters (Q33353210) (← links)
• FoxO1 links hepatic insulin action to endoplasmic reticulum stress (Q34132566) (← links)
• Reactive oxygen species suppress cardiac NaV1.5 expression through Foxo1. (Q34188064) (← links)
• Increased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intolerance. (Q34389068) (← links)
• Hepatic insulin production for type 1 diabetes (Q34432920) (← links)
• A role of apolipoprotein D in triglyceride metabolism (Q34559829) (← links)
• Evolution of hepatic steatosis to fibrosis and adenoma formation in liver-specific growth hormone receptor knockout mice (Q34730646) (← links)
• Challenges for gene therapy of type 1 diabetes. (Q35023262) (← links)
• Impaired insulin secretion and enhanced insulin sensitivity in cholecystokinin-deficient mice. (Q35063215) (← links)
• Liver-specific inducible nitric-oxide synthase expression is sufficient to cause hepatic insulin resistance and mild hyperglycemia in mice. (Q35266454) (← links)
• FoxO6 integrates insulin signaling with gluconeogenesis in the liver. (Q35405206) (← links)
• Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice. (Q35860656) (← links)
• Central effects of humanin on hepatic triglyceride secretion (Q35916831) (← links)
• FoxO1 Plays an Important Role in Regulating β-Cell Compensation for Insulin Resistance in Male Mice. (Q36625105) (← links)
• FoxO6 in glucose metabolism (FoxO6) (Q36854236) (← links)
• Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice. (Q37078689) (← links)
• ATF4 protein deficiency protects against high fructose-induced hypertriglyceridemia in mice. (Q37132127) (← links)
• PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1 (Q37149423) (← links)
• Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism (Q37149810) (← links)
• FoxO1 links insulin resistance to proinflammatory cytokine IL-1beta production in macrophages. (Q37400789) (← links)
• FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver. (Q37648011) (← links)
• Overexpression of apolipoprotein C-III decreases secretion of dietary triglyceride into lymph (Q37727877) (← links)
• FoxO1 and hepatic lipid metabolism (Q37805344) (← links)
• SMAD3/Stat3 Signaling Mediates β-Cell Epithelial-Mesenchymal Transition in Chronic Pancreatitis-Related Diabetes. (Q38642391) (← links)
• FoxO integration of insulin signaling with glucose and lipid metabolism. (Q39141439) (← links)
• Foxo1 mediates insulin action on apoC-III and triglyceride metabolism. (Q40301333) (← links)
• Glucose-regulated insulin production in the liver improves glycemic control in type 1 diabetic mice (Q41429641) (← links)
• Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. (Q44043194) (← links)
• Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. (Q44816724) (← links)
• Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes. (Q46268603) (← links)
• Sex- and Tissue-Specific Role of Estrogen Sulfotransferase in Energy Homeostasis and Insulin Sensitivity (Q47630924) (← links)
• APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice. (Q51172839) (← links)
• Forkhead Box Protein 1 (FoxO1) Inhibits Accelerated β Cell Aging in Pancreas-specific SMAD7 Mutant Mice. (Q51213864) (← links)
• Effect of hepatic insulin expression on lipid metabolism in diabetic mice. (Q53551509) (← links)
• FoxO6-mediated IL-1β induces hepatic insulin resistance and age-related inflammation via the TF/PAR2 pathway in aging and diabetic mice (Q64082459) (← links)
• Angiopoietin-1 production in islets improves islet engraftment and protects islets from cytokine-induced apoptosis (Q64377086) (← links)
• Sirolimus is associated with reduced islet engraftment and impaired beta-cell function (Q80175258) (← links)
• Deficiency in AIM2 induces inflammation and adipogenesis in white adipose tissue leading to obesity and insulin resistance (Q90070282) (← links)
• A Noncanonical Role for Plasminogen Activator Inhibitor Type 1 in Obesity-Induced Diabetes (Q91760095) (← links)
• Depletion of hepatic forkhead box O1 does not affect cholelithiasis in male and female mice (Q91785821) (← links)
• Altered FoxO1 and PPARγ interaction in age-related ER stress-induced hepatic steatosis (Q93070974) (← links)
• Liver-specific inducible nitric-oxide synthase expression is sufficient to cause hepatic insulin resistance and mild hyperglycemia in mice (Q93542926) (← links)